Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), greatest decrease (Expand Search)
Showing 561 - 580 results of 21,342 for search '(( significant ((genes decrease) OR (greater decrease)) ) OR ( significant decrease decrease ))', query time: 0.37s Refine Results
  1. 561
    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.

    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 562
    miR-1247-3p was downregulated in CRC resistant cells.

    miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 563
    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.

    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 564
    miR-1247-3p plasmid.

    miR-1247-3p plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 565
    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.

    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 566
    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures.

    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 567
    Dual luciferase primer.

    Dual luciferase primer. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 568
    shCCND1 plasmid.

    shCCND1 plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 569
    CCND1 promoted chemoresistance in CRC.

    CCND1 promoted chemoresistance in CRC. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 570
    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.

    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 571
    Western blot analysis of drug combinations.

    Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 572
    ALKL1196M –ABT199 interactions.

    ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 573
    Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells.

    Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 574
    ALK<sup>wt</sup>–ABT199 interactions.

    ALK<sup>wt</sup>–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 575
    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression.

    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 576
    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.

    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 577
    Effect of miR-1247-3p on survival in colorectal cancer patients.

    Effect of miR-1247-3p on survival in colorectal cancer patients. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 578
    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.

    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 579
    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment.

    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 580
    S1 Raw images -

    S1 Raw images - by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: